Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Skin cancer, melanoma
Trial Type:  Treatment
Treatment/Intervention:  vaccine therapy
Results 1-16 of 16 for your search:
Start Over
Vaccine Therapy and Iscomatrix with or without Cyclophosphamide and Celecoxib in Treating Patients with Thoracic Malignancies or Tumors That Have Spread to the Chest Cavity
Status: Temporarily closed
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 14-C-0053, NCI-2014-02465, 140053, 348360, P131392, NCT02054104
ISF35 and Pembrolizumab in Treating Patients with Refractory Metastatic Stage IIIB-IV Melanoma
Status: Not yet active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 2015-0199, NCI-2016-00672, NCT02719015
Gene Therapy and Vaccine Therapy after a Conditioning Regimen in Treating Patients with Stage IIIC-IV Melanoma
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 08-02-020, NCI-2010-00229, 0802-901, 10-001212, 1600, 53.08.0-h, 53.0B.0·h, MART-1 F5 TCR, OB02·901, NCT00910650
Vaccine Therapy and Dasatinib in Treating Patients With Stage IIIB-IV Melanoma
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: Over 18
Trial IDs: 12-048, NCI-2013-01905, NCT01876212
Epacadostat and Vaccine Therapy in Treating Patients with Stage III-IV Melanoma
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CITN-04, NCI-2013-01605, NCT01961115
Immunotherapy Study for Patients With Stage IV Melanoma
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: NLG0304, NCI-2014-00700, 1303-1217, NCT02054520
Phase IIB TL + YCWP + DC in Melanoma
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: WIRB Protocol: 20141932, NCI-2014-02585, NCT02301611
Vaccine Therapy in Treating Patients with Advanced Stage III-IV Melanoma
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: I 215912, NCI-2012-02231, NCT01744171
Vaccine Therapy in Treating Patients with Recurrent Stage IIIC-IV Melanoma
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 12-306, NCI-2013-01799, NCT01753089
Vaccine Therapy in Treating Patients with Stage IIIB-IV Melanoma
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 13-240, NCI-2014-00958, NCT01970358
Phase 1 Study of Intradermal LV305 in Patients With Locally Advanced, Relapsed or Metastatic Cancer Expressing NY-ESO-1
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: ID-LV305-2013-001, NCI-2014-01153, NCT02122861
A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: BBI-DSP7888-101, NCI-2015-01357, NCT02498665
Vaccine Therapy in Treating Patients with Relapsed or Refractory Melanoma That Express GD2
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 65
Trial IDs: Mel-2012-01-01, NCI-2016-00416, STUDY00002217, NCT02482532
Phase 1 Study of GRN-1201 in HLA-A*02 Subjects With Resected Melanoma
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: GRN1201-001, NCI-2016-01132, NCT02696356
Start Over